(Q50875555)

24 March 2018

title

Comparison of combined, biochemical and nuchal translucency screening for Down syndrome in first trimester in Northern Finland. (English)

1 reference

24 March 2018

0 references

1 reference

Sini Peuhkurinen

1

1 reference

24 March 2018

Paivi Laitinen

2

1 reference

24 March 2018

Timppa Honkasalo

3

1 reference

24 March 2018

Markku Ryynanen

4

1 reference

24 March 2018

Jaana Marttala

5

1 reference

24 March 2018

publication date

9 April 2013

1 reference

24 March 2018

Acta Obstetricia et Gynecologica Scandinavica

published in

1 reference

24 March 2018

volume

92

1 reference

24 March 2018

issue

7

1 reference

24 March 2018

page(s)

769-774

1 reference

24 March 2018

Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

Increased nuchal translucency with normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

First-trimester or second-trimester screening, or both, for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

Prospective validation of first-trimester combined screening for trisomy 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

Maternal serum screening for Down syndrome in the first trimester: experience from Belarus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

Appropriate biochemical parameters in first-trimester screening for Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

Increased nuchal translucency as a marker for fetal chromosomal defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

Nuchal translucency and nasal bone in first-trimester ultrasound screening for aneuploidy in multiple pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

Nuchal translucency measurements: frequency distribution and changes with gestation in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.12095

21 January 2018

Identifiers

DOI

10.1111/AOGS.12095

1 reference

24 March 2018

1 reference

24 March 2018